Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
19.62
+0.16 (0.82%)
Nov 10, 2026, 4:00 PM EST - Market closed
Braveheart Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +129.36% | Nov 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $40 | Buy | Maintains | $40 | +103.87% | Nov 7, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $48 | Buy | Maintains | $48 | +144.65% | Sep 9, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 31, 2026 |
| Jefferies No rating | Jefferies | Buy Initiates $48 | Buy | Initiates | $48 | +144.65% | Aug 31, 2026 |